论文部分内容阅读
目的:观察阿奇霉素胃肠道反应的发生情况,证实蒙脱石的防治作用。方法:回顾性分析笔者所在医院2012年1月—2014年8月儿科应用阿奇霉素的患儿80例发生胃肠反应的情况,将其分为对照组与治疗组,对照组40例静滴阿奇霉素,治疗组40例在静滴阿奇霉素前服用蒙脱石散3g。结果:对照组胃肠反应的发生率为60%,治疗组胃肠反应的发生率为17.5%,差异具有统计学意义(P<0.05)。结论:蒙脱石散在患者静滴阿奇霉素前服用有较好的防治胃肠反应的效果。
Objective: To observe the occurrence of azithromycin gastrointestinal reactions, confirmed the prevention and treatment of montmorillonite. Methods: A retrospective analysis of the author’s hospital from January 2012 to August 2014 pediatric azithromycin 80 cases of gastrointestinal reactions, divided into control group and treatment group, control group 40 patients intravenous azithromycin, Treatment group, 40 cases of intravenous azithromycin before taking montmorillonite powder 3g. Results: The incidence of gastrointestinal reactions in the control group was 60%, and the incidence of gastrointestinal reactions in the treatment group was 17.5%. The difference was statistically significant (P <0.05). Conclusion: Montmorillonite scattered before taking intravenous azithromycin in patients with better prevention and treatment of gastrointestinal reactions.